A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer

NCT00215345 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

66

Enrollment

FED

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Taxotere
DRUG: Celecoxib

Sponsor

Department of Veterans Affairs, New Jersey

Collaborators

[object Object]
[object Object]